S1 Biopharma, Inc.
PrivateLast Round
IPO
Jun 25, 2015
Est. Valuation
$106M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
S1 Biopharma, Inc. is a biopharmaceutical company that develops non-hormonal drug therapies for the treatment of sexual dysfunction in women and men.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
S1 Biopharma, Inc. Comparables
Compare S1 Biopharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sprout Pharmaceuticals, Inc. | 84% | |
| JASTLabs Corp | 77% | |
| Arletta Pharma Solutions | 77% | |
S1 Biopharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jun 25, 2015 |
S1 Biopharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Northland Securities, Inc. | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors grew 1323% MoM, from 61 to 868.
- Jan 22, 2026
Monthly visitors increased 281% MoM, reaching 419.
S1 Biopharma, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about S1 Biopharma, Inc.'s valuation, stock price, and market status.